Ketalux - Ketamine Therapy EducationKetalux - Mental Wellness Authority
DEA · Final action

Ketamine is a Schedule III controlled substance under federal law

Ketamine is listed in Schedule III of the Controlled Substances Act. Prescribing, dispensing, recordkeeping, and storage are subject to DEA registration requirements, and state controlled-substance rules apply in addition to federal ones.

Written by: Ira ZootMedical review status: Pending clinical reviewLast updated: August 24, 2026Evidence: Primary government source

Record details

Agency
DEA
Jurisdiction
United States (federal)
Status
Final action
Published
1999
Effective
Not applicable / not verified
Expires
Not applicable / not verified
Last checked
August 24, 2026

Why it matters

Scheduling drives who may prescribe, how telehealth prescribing is regulated, and what a legitimate clinic's compliance posture should look like.

Primary source

DEA — Controlled Substances Act schedules

Not legal advice
Regulatory information is educational and may change. Verify current requirements with the appropriate agency or qualified counsel. Ketalux does not provide legal advice.

Back to the Regulatory Tracker.

About the author

Founder and publisher of Ketalux, based in Chicago, Illinois. Ketalux.com is owned and operated by iDigits LLC. Ira commissions and edits the site's articles and believes ketamine therapy — used responsibly — offers real hope for people living with depression, anxiety, PTSD, and chronic pain. Contact: ira@idigits.com.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.